Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rang in aandelen #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Aandeelprijs
$93.80
Laatst gesynchroniseerd: 2025-04-28
Marktkapitalisatie
$2.68B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Aerovate Therapeutics, Inc. (AVTE)

Categorie

Koersgeschiedenis voor Aerovate Therapeutics, Inc. (AVTE)
Hoogste slotkoers: $92.05 op 2025-04-01

Laagste slotkoers: $799.05 op 2021-06-01
Koersgeschiedenis van Aerovate Therapeutics, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 1.25%
2024 -86.27%
2023 -23.84%
2022 125.16%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$549.38 41.20%
US
$1.05K 47.75%
NL
$148.35 491.02%
US
$122.63 -12.65%
AU
$762.91 6.87%
CH